These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 14871019

  • 41. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG, Serbul VM, Ageev FT.
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [Abstract] [Full Text] [Related]

  • 42. Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
    White M, Rouleau JL, Afzal R, Floras J, Yusuf S, McKelvie RS.
    Ther Adv Cardiovasc Dis; 2009 Apr; 3(2):113-21. PubMed ID: 19299427
    [Abstract] [Full Text] [Related]

  • 43. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
    Grandi AM, Solbiati F, Laurita E, Maresca AM, Nicolini E, Marchesi C, Gianni M, Guasti L, Venco A.
    Am J Hypertens; 2008 Feb; 21(2):231-7. PubMed ID: 18174880
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A, Finckenberg P, Korpi A, Loytainen M, Martonen E, Levijoki J, Mervaala E.
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [Abstract] [Full Text] [Related]

  • 46. Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension.
    Nakamoto M, Ohya Y, Shinzato T, Mano R, Yamazato M, Sakima A, Takishita S.
    Hypertens Res; 2008 Feb; 31(2):353-61. PubMed ID: 18360056
    [Abstract] [Full Text] [Related]

  • 47. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A, Battegay E.
    Praxis (Bern 1994); 2005 Apr 13; 94(15):581-94. PubMed ID: 15884724
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
    McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA, CHARM Investigators and Committees.
    Lancet; 2003 Sep 06; 362(9386):767-71. PubMed ID: 13678869
    [Abstract] [Full Text] [Related]

  • 51. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS, Cao H, Yang T.
    Acta Pharmacol Sin; 2000 Nov 06; 21(11):1043-7. PubMed ID: 11501062
    [Abstract] [Full Text] [Related]

  • 52. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT, Wiedmann RT, Greenland BD, Lynch JJ, Grossman W.
    Cardiovasc Res; 1998 Aug 06; 39(2):413-22. PubMed ID: 9798526
    [Abstract] [Full Text] [Related]

  • 53. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG, de Gasparo M, Whitebread S, Hebbar L, Clair MJ, Melton DM, Krombach RS, Mukherjee R, Iannini JP, O SJ.
    Circulation; 1997 Oct 07; 96(7):2385-96. PubMed ID: 9337215
    [Abstract] [Full Text] [Related]

  • 54. Candesartan: from left ventricular hypertrophy to heart failure, a global approach.
    Barrios V, Escobar C, Calderon A.
    Expert Rev Cardiovasc Ther; 2007 Sep 07; 5(5):825-34. PubMed ID: 17867913
    [Abstract] [Full Text] [Related]

  • 55. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K, Kobayashi N, Watanabe S, Tsubokou Y, Matsuoka H.
    Am J Hypertens; 2001 Apr 07; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
    Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K, CHARM Investigators and Committees.
    Lancet; 2003 Sep 06; 362(9386):772-6. PubMed ID: 13678870
    [Abstract] [Full Text] [Related]

  • 59. Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertension.
    Maitland K, Bridges L, Davis WP, Loscalzo J, Pointer MA.
    Circulation; 2006 Aug 29; 114(9):905-11. PubMed ID: 16923758
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.